Evidence map›Paper›PMID 12076996›Full record

ArticleBrain : a journal of neurology2002

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Claudia F Lucchinetti, Raul N Mandler, Dorian McGavern, Wolfgang Bruck, Gerald Gleich, Richard M Ransohoff, Corinna Trebst, Brian Weinshenker, Dean Wingerchuk, Joseph E Parisi and 1 more

Open access · greenAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 446 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
446citing papers in PubMed, 3 pooled it
17.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

446 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,197 citations in OpenAlex.

  1. A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica.Annals of clinical and translational neurology · 2021
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

386 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Claudia F LucchinettiDepartment of Neurology, Mayo Clinic, Rochester, MN, USA. lucchinetti.claudia@mayo.edu
Raul N Mandler
Dorian McGavern
Wolfgang Bruck
Gerald Gleich
Richard M Ransohoff
Corinna Trebst
Brian Weinshenker
Dean Wingerchuk
Joseph E Parisi
Hans Lassmann
Mayo Clinic · US

Funding

CELLULAR IMMUNE RESPONSE AND NEURAL DYSFUNCTIONF31MH012120 · NIMH · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI MCGAVERN, DORIAN B · 1998 to 1999
–
NIMH NIH HHS F31 MH012120
6 · The paper itself

Abstract

Devic's disease [neuromyelitis optica (NMO)] is an idiopathic inflammatory demyelinating disease of the CNS, characterized by attacks of optic neuritis and myelitis. The mechanisms that result in selective localization of inflammatory demyelinating lesions to the optic nerves and spinal cord are unknown. Serological and clinical evidence of B cell autoimmunity has been observed in a high proportion of patients with NMO. The purpose of this study was to investigate the importance of humoral mechanisms, including complement activation, in producing the necrotizing demyelination seen in the spinal cord and optic nerves. Eighty-two lesions were examined from nine autopsy cases of clinically confirmed Devic's disease. Demyelinating activity in the lesions was immunocytochemically classified as early active (21 lesions), late active (18 lesions), inactive (35 lesions) or remyelinating (eight lesions) by examining the antigenic profile of myelin degradation products within macrophages. The pathology of the lesions was analysed using a broad spectrum of immunological and neurobiological markers, and lesions were defined on the basis of myelin protein loss, the geography and extension of plaques, the patterns of oligodendrocyte destruction and the immunopathological evidence of complement activation. The pathology was identical in all nine patients. Extensive demyelination was present across multiple spinal cord levels, associated with cavitation, necrosis and acute axonal pathology (spheroids), in both grey and white matter. There was a pronounced loss of oligodendrocytes within the lesions. The inflammatory infiltrates in active lesions were characterized by extensive macrophage infiltration associated with large numbers of perivascular granulocytes and eosinophils and rare CD3(+) and CD8(+) T cells. There was a pronounced perivascular deposition of immunoglobulins (mainly IgM) and complement C9neo antigen in active lesions associated with prominent vascular fibrosis and hyalinization in both active and inactive lesions. The extent of complement activation, eosinophilic infiltration and vascular fibrosis observed in the Devic NMO cases is more prominent compared with that in prototypic multiple sclerosis, and supports a role for humoral immunity in the pathogenesis of NMO. Based on this study, future therapeutic strategies designed to limit the deleterious effects of complement activation, eosinophil degranulation and neutrophil/macrophage/microglial activation are worthy of further investigation.

Indexed as

Antibody FormationAxonsCD3 ComplexCD8-Positive T-LymphocytesComplement ActivationEosinophilsHumansImmunoglobulinsImmunohistochemistryMacrophagesMyelin SheathNeuromyelitis OpticaOligodendrogliaOptic NerveSpinal CordT-LymphocytesCD3 ComplexImmunoglobulins

Identifiers

PMID12076996
PMCPMC5444467
OpenAlexW2161681716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.